Abstract

Chagas disease is still a major tropical diseasein Latin America, affecting 16 to 18 million people.About 6 million people are infected with thecausative organism, Trypanosoma cruzi , in Brazil[1]. However, it often remains for decades in itsindeterminate form, symptomless, with tissue injuryin about 30% of the cases, which eventually willevolve to serious arrhythmia and sudden death [1].There is no effective clinical or laboratorytechnique to monitor chronic Chagas myocarditis.Several researchers have found that Troponin I andT are important biochemical markers of heartmuscle damage. Increased levels of myocardialtroponins have been found associated with acutemyocardial ischemia, infarction, myocarditis andheart failure [2-4].Recently, we tested sera from 60 Chagasdisease patients (24 with the indeterminate formand 36 with chronic chagasic cardiomyopathy. Serafrom 24 healthy volunteers (Control Group) weretested for Troponin I (Immulite 1000 Turbo DPC-Medlab). The Troponin I value was considerednormal when it was below 0.15ng/dl, and high whenit was above 0.30ng/dl. The upper limit was set tobe at least two standard deviations above thenormal value.The mean value for Troponin I was 0.46ng/dl inthe Chagas disease patients, and 0.027ng/dl in thecontrol group. The mean age was 44.1±9.9 yearsof the Chagas patients, and 34 were male. Whenwe tested We found 13 (54%) and 26 (74%)patients with high Troponin I, respectively, forchronic Chagas cardiomyopathy and theindeterminate form of Chagas disease. Twenty-onepatients from the Chagas disease group wereexcluded due to other cardiovascular diseases,myopathy or kidney disease.Troponin I levels were significantly higher amongthe Chagas disease patients with cardiomyopathywhen compared to the indeterminate form andcontrols, mean 0.60ng/dl vs 0.25ng/dl, respectively,and controls 0.027ng/dl (P < 0.001).All the patients with the indeterminate form ofChagas disease had normal EKGs, chest X-raysand echocardiograms. Possibly, the increased levelsof Troponin I, found in our sample, are related tochronic foci of myocardial inflammation, provokedby Chagas disease.Moreover, the utilization of a sensitive and easilymeasured biochemical marker should allow us toadopt different clinical cut-offs, facilitating theidentification of the different degrees of myocardialdamage, which now requires various diagnostic andtherapeutic approaches [5].The serum level of Troponin I is elevated indifferent clinical presentations of Chagas’ diseaseand may become an important element for earlydetection of myocardial inflammation, to preventfurther myocardial damage.References

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.